Trials / Completed
CompletedNCT03268525
The Effect of Local Anesthesia on Postoperative Pain in Vaginal Hysterectomy
The Effect of Local Anesthesia on Postoperative Pain in Vaginal Hysterectomy: A Randomized Controlled Trial
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Wolfson Medical Center · Other Government
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The investigators aim is to study the effect of pre-operative local anesthetic on post vaginal hysterectomy pain.
Detailed description
This is a double-blinded, randomized, controlled trial. Women who undergone elective vaginal hysterectomy and gave their informed consent were included. Exclusion criteria included additional abdominal, chronic pelvic pain, malignancy, and allergy to Bupivacaine. Solutions of either Bupivacaine-Hydrochloride 0.5%, or Sodium-Chloride 0.9% as a placebo, were prepared prior to surgery, according to randomization. The chosen solution was injected before incision, as a modified paracervical block, and in each resection line (sacro-uterine and cardinal ligaments). The amount of fluid administered was 10 ml. When colporrhaphy was also performed, an additional 5 ml of solution were injected in the midline of the vaginal wall prior to each incision line. By utilizing the 10 cm Visual-analogue-scale (VAS) we examined the differences in post-operative pain at rest at 3, 8, and 24 hours, and during ambulation at 8 and 24 hours using multivariate linear regression models. We also assessed the differences in analgesics given at the different time points between the groups using multivariate negative binomial regression models.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Marcaine 0.5 % Injectable Solution | Local infiltration by Marcaine 0.5% Injectable Solution prior to incision |
| DRUG | Sodium Chloride 0.9% | Local infiltration by Sodium Chloride 0.9% prior to incision |
Timeline
- Start date
- 2017-09-01
- Primary completion
- 2019-11-30
- Completion
- 2019-11-30
- First posted
- 2017-08-31
- Last updated
- 2020-06-09
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT03268525. Inclusion in this directory is not an endorsement.